85 related articles for article (PubMed ID: 19242795)
1. Coronary artery disease in patients with liver cirrhosis.
Kalaitzakis E; Rosengren A; Skommevik T; Björnsson E
Dig Dis Sci; 2010 Feb; 55(2):467-75. PubMed ID: 19242795
[TBL] [Abstract][Full Text] [Related]
2. Arterial hypertension as a comorbidity of cirrhosis.
Pitrone C; Saitta C; Alibrandi A; Raimondo G
Dig Liver Dis; 2023 Dec; 55(12):1779-1781. PubMed ID: 37838565
[No Abstract] [Full Text] [Related]
3. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study.
An J; Shim JH; Kim SO; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Circulation; 2014 Oct; 130(16):1353-62. PubMed ID: 25095888
[TBL] [Abstract][Full Text] [Related]
4. Coronary artery stents and antiplatelet therapy in patients with cirrhosis.
Russo MW; Pierson J; Narang T; Montegudo A; Eskind L; Gulati S
J Clin Gastroenterol; 2012 Apr; 46(4):339-44. PubMed ID: 22105182
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation.
Patel SS; Nabi E; Guzman L; Abbate A; Bhati C; Stravitz RT; Reichman T; Matherly SC; Driscoll C; Lee H; Luketic VA; Sterling RK; Sanyal AJ; Patel V; Levy M; Siddiqui MS
Liver Transpl; 2018 Mar; 24(3):333-342. PubMed ID: 29328556
[TBL] [Abstract][Full Text] [Related]
6. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.
Simon TG; Henson J; Osganian S; Masia R; Chan AT; Chung RT; Corey KE
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2776-2784.e4. PubMed ID: 31077838
[TBL] [Abstract][Full Text] [Related]
7. Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality.
Krill T; Brown G; Weideman RA; Cipher DJ; Spechler SJ; Brilakis E; Feagins LA
Aliment Pharmacol Ther; 2017 Jul; 46(2):183-192. PubMed ID: 28488370
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Coronary Intervention in Patients With End-Stage Liver Disease.
Singh V; Patel NJ; Rodriguez AP; Shantha G; Arora S; Deshmukh A; Cohen MG; Grines C; De Marchena E; Badheka A; Ghatak A
Am J Cardiol; 2016 Jun; 117(11):1729-34. PubMed ID: 27103158
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of coronary artery disease in patients with liver cirrhosis: a meta-analysis.
Zhao J; Li N; Sun H; Liang C
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):118-120. PubMed ID: 29194187
[No Abstract] [Full Text] [Related]
10. Experimental Liver Cirrhosis Inhibits Restenosis after Balloon Angioplasty.
Mechelinck M; Hein M; Kupp C; Braunschweig T; Helmedag MJ; Klinkenberg A; Habigt MA; Klinge U; Tolba RH; Uhlig M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511114
[TBL] [Abstract][Full Text] [Related]
11. Cardiac risk stratification of the liver transplant candidate: A comprehensive review.
Nagraj S; Peppas S; Rubianes Guerrero MG; Kokkinidis DG; Contreras-Yametti FI; Murthy S; Jorde UP
World J Transplant; 2022 Jul; 12(7):142-156. PubMed ID: 36051452
[TBL] [Abstract][Full Text] [Related]
12. Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury.
Gîrleanu I; Trifan A; Huiban L; Muzîca C; Petrea OC; Sîngeap AM; Cojocariu C; Chiriac S; Cuciureanu T; Costache II; Stanciu C
Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888123
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease.
Ostojic Z; Ostojic A; Bulum J; Mrzljak A
World J Cardiol; 2021 Nov; 13(11):599-607. PubMed ID: 34909126
[TBL] [Abstract][Full Text] [Related]
14. Management of Acute Coronary Syndrome in Patients with Liver Cirrhosis.
Ahmed T; Grigorian AY; Messerli AW
Am J Cardiovasc Drugs; 2022 Jan; 22(1):55-67. PubMed ID: 34050893
[TBL] [Abstract][Full Text] [Related]
15. Chronic renal dysfunction in cirrhosis: A new frontier in hepatology.
Kumar R; Priyadarshi RN; Anand U
World J Gastroenterol; 2021 Mar; 27(11):990-1005. PubMed ID: 33776368
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery disease and non-alcoholic fatty liver disease: Clinical correlation using computed tomography coronary calcium scans.
Kirby RS; Halegoua-DeMarzio D
JGH Open; 2021 Mar; 5(3):390-395. PubMed ID: 33732887
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice?
Buchard B; Boirie Y; Cassagnes L; Lamblin G; Coilly A; Abergel A
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31936597
[TBL] [Abstract][Full Text] [Related]
18. Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.
Wu VC; Chen SW; Chou AH; Ting PC; Chang CH; Wu M; Hsieh MJ; Wang CY; Chang SH; Lin MS; Hung KC; Hsieh IC; Chu PH; Wu CS; Lin YS
PLoS One; 2019; 14(10):e0223380. PubMed ID: 31581275
[TBL] [Abstract][Full Text] [Related]
19. The relationship between coronary artery disease and cardiovascular events early after liver transplantation.
Patel SS; Lin FP; Rodriguez VA; Bhati C; John BV; Pence T; Siddiqui MB; Sima AP; Abbate A; Reichman T; Siddiqui MS
Liver Int; 2019 Jul; 39(7):1363-1371. PubMed ID: 30848862
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017).
Badawi A; Di Giuseppe G; Arora P
PLoS One; 2018; 13(12):e0208839. PubMed ID: 30540839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
